Jiyan Biotech Debuts at Distrimap: Joining Hands with Distributors to Navigate the Industry Winter

In recent years, the biopharmaceutical industry has witnessed a diverse range of fortunes, with an overall sense of chill. After everyone has come to realize that the cold winter is unlikely to fade away on its own in the short term, it becomes particularly crucial to strive for ways to "break the situation."

The 2024 Distrimap Scientific Research Tools Innovation and Development and Distribution Channel Conference and the Scientific Research Tools Industry Chain Exhibition successfully concluded in Shanghai on December 7th. Manufacturers of reagents, instruments, consumables, and innovative technologies in the biopharmaceutical industry, as well as channel distributors, engaged in comprehensive exchanges and dialogues. Jiyan Biotech was invited to participate and presented a sincere communication and report to distributors and industry peers.

Jiyan Biotech's Keynote Speech: How to Be the First to "Seize the Opportunity"?

At present, the sub - fields of organoids mainly consist of upstream basic industry players, mid - stream technology development players, and downstream market application players. Judging from the maturity of industry development, the basic industry and technology research and development are experiencing a rapid growth trend in the niche market. This is mainly manifested in that the increasing demand for mid - stream technology development has led to a continuous rise in the demand for upstream imported raw materials. Domestic alternative raw materials are gradually entering the market. In mid - stream technology research and development, the number of cutting - edge articles published, the number of organoid companies, and the financing situation of organoid companies have all shown rapid growth compared with previous years. The development of the upstream and mid - stream sectors has presented a relatively clear profit model and a gradually maturing mid - front - end market.

With the development of technology and the market, the downstream terminal market, including clinical treatment and new drug development, urgently needs to be explored. Even some extended application fields, such as the food, environmental, and cosmetics industries, have started to pay close attention to and gradually introduce new technologies.

So, how can one be the first to "taste the crab" in the current organoid market, where there is much hype but little substance? Jiyan Biotech analyzes from five aspects: [Customers], [Market Segments], [Products], [Brand], and [Timing].

Why Choose Jiyan?You can count on us as your reliable partner!

In a market where everyone is engaged in price competition, Jiyan Biotech insists on producing products with high cost - performance and guaranteed services. This gives brand owners the confidence to stand before customers when collaborating with distributors and agents. Through technological accumulation, Jiyan Biotech has developed and refined a series of functional products in the organoid technology and application sectors, meeting the needs of customers at different growth stages. For example, there is the "one - stop" organoid construction kit, which allows novice customers to get ahead. It is designed for beginners and has the characteristics of zero foundation and ready - to - use.At the same time, Jiyan Biotech provides attentive support for novice customers on the path of organoid construction. We promise to offer a value - added service of free reconstruction for customers who purchase the kit if their organoid construction fails.For mature customers who have already mastered the technology, with the aim of solving customer pain points,Jiyan Biotech has independently developed a series of small but useful tools for organoid identification and uniform drug screening:

1.SE-Gel

It is a specialized tissue embedding gel for organoids, suitable for both paraffin and frozen sections. Compared with traditional agarose, SE-Gel features high biocompatibility, excellent mechanical toughness, and is less likely to break during sectioning, resulting in a higher sectioning yield.  

2.SCTC

It is a kit for in-situ fixation, embedding and frozen sectioning of matrix collagen. To meet the needs of some customers who require direct fixation and embedding without removing the gel, Jiyan Biotech has further developed a special kit for in-situ fixation of the matrix gel and organoids within the gel without removing the collagen, as well as for subsequent frozen sectioning. This kit is highly favored by customers.

3.GF996

In order to avoid the influencing factors of unclear components in the drug screening process, Jiyan Biotech has independently developed the GF996 culture and detection plate. This plate is independent of matrix gel, features high-throughput, enables uniform 3D cell/organoid culture, and integrates the functions of culture and detection into one.  

Be friends with time.Be friends with Jiyan!

To be friends with time is to be friends with the market. In the process of time - tested development, maintaining a sense of awe for high - quality innovative technologies is the path of self - cultivation for a technology - innovation - driven enterprise. We hope to meet more like - minded partners on this journey and work together to weather the industry winter. We welcome you to be friends with Jiyan. Feel free to contact us for inquiries!

-END-